Symposium Bioproduction 2010

On December 14, 2010, Genopole® will hold the third edition of its Biomanufacturing Symposium, entitled “30 years of therapeutic product biomanufacturing: outcomes and outlook”.

Following the success of the two previous editions of the Biomanufacturing Symposium, Genopole® will broaden its outlook and ask the following question: which expression systems, compounds, technologies, drug targets and business models will be critically important in biomanufacturing in the future?

The symposium will open with a mini-session on 30 years of therapeutic product biomanufacturing: key dates, success stories, limitations and opportunities (molecules, drug targets, expression systems, technologies; etc.).

This will be followed by three main sessions:

Alternative expression systems

• What has changed in the 4 years since the first Biomanufacturing Symposium in terms of the systems under development at the time (transgenic animals and plants)?
• What is the outlook for the more “exotic” systems (e.g. carnivorous plants, hairy roots, Lemna, microalgae, ciliates, edible vaccines; etc.)?
• Should these alternatives be considered as new expressions system per se or rather as reservoirs of novel compounds (a transgenic approach versus a conventional screening approach)?

Implementing alternative expression systems via the development of appropriate technologies

• How should researchers and equipment manufacturers interact?
• Will these alternative expression systems become a true industrial option?
• Biomanufacturing and synthetic biology: the first industrial successes

Biosimilars and biogenerics: the outlook

The first biologics are coming off patent: regulatory definitions, perspectives and the impact on the price of biologic

Extra

On December 15 and 16, Genopole® and the Epigenomics Program are organizing an International Synthetic Biology Conference, which will follow on from the Biomanufacturing Symposium.

Biomanufacturing Symposium delegates can register for the Synthetic Biology Conference at a special rate of €50.

[+]For more information on the program and how to registration: http://syntheticbiology2010.genopole.fr

LANGUAGES OF THE COLLOQUIUM

Presentation will be given in English or French depending on the speakers but a simultaneous interpreting service will be provided in both languages

INFORMATION - CONTACT

  Meignen Catherine
  Valérie Larivière , assistant of Genopole Research
GIP Genopole®, Genopole® Campus 1 - Bâtiment G8
5, rue Henri Desbruères
F-91030 Evry Cedex, France

 Tel.: +33 160 878 440
 Fax: +33 160 873 500
 Mail